Clinical trial
Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced…
NCT00307450 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00307450 |
|---|---|
| Title | Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease |
| Official title | Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease (LeLeDys Study) - A Multicenter, Randomized, Stratified, Double-blinded, Placebo-controlled Phase IV Study |
| Acronym | LeLeDys |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | UCB Pharma GmbH Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 34 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Mar 28, 2006 |
| Last update posted | Aug 3, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: